- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03385824
Self-Advocacy for Independent Life (SAIL) After TBI
July 7, 2020 updated by: Lenore Hawley, Craig Hospital
Self-Advocacy for Independent Life (SAIL) After Traumatic Brain Injury
Traumatic brain injury (TBI) has been conceptualized as a chronic health condition, warranting self-advocacy for health management services across the lifespan.
Successful self-advocacy requires a combination of cognitive and communication skills (problem solving, organization, negotiation, etc), which may be impaired following TBI.
This project focuses on developing and testing the efficacy of an intervention to enhance self-advocacy skills in individuals who have sustained TBI.
This two-arm, randomized controlled trial will include approximately 74 participants, recruited in 4 waves of approximately 18-20 per wave, with each wave recruited from a different geographic area of the state.
The primary hypothesis states that participants receiving the treatment intervention will demonstrate significantly greater improvements in self-advocacy beliefs (SAS) from baseline to post-intervention as compared to participants in the control group.
Treatment will consist of interactive 4-session workshops along with 2 booster phone calls.
Control participants will receive a copy of a self-advocacy workbook after all assessments are completed.
Baseline, post-treatment and two follow-up assessments will take place.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
76
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Englewood, Colorado, United States, 80113
- Craig Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Documented TBI due to an external mechanical force
- Received inpatient or outpatient rehabilitation for TBI
- At least 9 months post TBI
- Able to travel independently in the community
- Able to attend intervention sessions
Exclusion Criteria:
- Unable to read or speak English well enouth to complete assessments and actively participate in study intervention
- Currently in inpatient TBI rehabilitation
- Previously participated in a SAIL program
- Participating in another research trial
- Unable to perform neuropsychological baseline assessment
- Score of 30 or above on GSES
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Self-Advocacy for Independent Life (SAIL)
10 week treatment program to improve self-advocacy skills.
Includes 4 in-person group sessions (3 hours per session) and two supportive phone calls; workbook and home assignments.
|
SAIL program is based on an interactive workshop model.
In -person sessions will focus on: enhancement of self-efficacy beliefs; enhancement of knowledge of TBI self-advocacy information; group process to instill hope and universality; and practice of self-advocacy behaviors in a supportive neuro-rehabilitation structured group environment.
|
|
No Intervention: Control
SAIL workbook provided at the conclusion of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-Advocacy Scale (SAS)
Time Frame: Change in SAS score from Baseline to 11 weeks (immediately post-tx)
|
The Self-Advocacy Scale (SAS) is an eight-item 1-4 Likert rating scale (1 = not confident to 4 = very confident), conceptualized as a domain specific self-efficacy scale.
The SAS is designed to measure an individual's current beliefs about his or her ability to produce desired self-advocacy outcomes.
Scores range from 8 to 32 with higher scores indicative of better self-advocacy skills.
|
Change in SAS score from Baseline to 11 weeks (immediately post-tx)
|
|
Self-Advocacy Scale (SAS)
Time Frame: Change in SAS score from Baseline to 17 weeks (6 weeks post-tx)
|
The Self-Advocacy Scale (SAS) is an eight-item 1-4 Likert rating scale (1 = not confident to 4 = very confident), conceptualized as a domain specific self-efficacy scale.
The SAS is designed to measure an individual's current beliefs about his or her ability to produce desired self-advocacy outcomes.
Scores range from 8 to 32 with higher scores indicative of better self-advocacy skills.
|
Change in SAS score from Baseline to 17 weeks (6 weeks post-tx)
|
|
Self-Advocacy Scale (SAS)
Time Frame: Change in SAS score from Baseline to 23 weeks (12 weeks post-tx)
|
The Self-Advocacy Scale (SAS) is an eight-item 1-4 Likert rating scale (1 = not confident to 4 = very confident), conceptualized as a domain specific self-efficacy scale.
The SAS is designed to measure an individual's current beliefs about his or her ability to produce desired self-advocacy outcomes.
Scores range from 8 to 32 with higher scores indicative of better self-advocacy skills.
|
Change in SAS score from Baseline to 23 weeks (12 weeks post-tx)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Personal Advocacy Activity Scale (PAAS)
Time Frame: Change in PAAS score from Baseline to 11 weeks (immediately post-tx)
|
The Personal Advocacy Activity Scale (PAAS) is a 12-item self-rating of personal advocacy behaviors.
Participants respond to each item by indicating how frequently they perform each activity, "Not at all", "1 - 4 times", or "5 or more times".
Scores range from 12 to 36 with higher scores indicating more personal advocacy behavior.
|
Change in PAAS score from Baseline to 11 weeks (immediately post-tx)
|
|
Personal Advocacy Activity Scale (PAAS)
Time Frame: Change in PAAS score from Baseline to 17 weeks (6 weeks post-tx)
|
The Personal Advocacy Activity Scale (PAAS) is a 12-item self-rating of personal advocacy behaviors.
Participants respond to each item by indicating how frequently they perform each activity, "Not at all", "1 - 4 times", or "5 or more times".
Scores range from 12 to 36 with higher scores indicating more personal advocacy behavior.
|
Change in PAAS score from Baseline to 17 weeks (6 weeks post-tx)
|
|
Personal Advocacy Activity Scale (PAAS)
Time Frame: Change in PAAS score from Baseline to 23 weeks (12 weeks post-tx)
|
The Personal Advocacy Activity Scale (PAAS) is a 12-item self-rating of personal advocacy behaviors.
Participants respond to each item by indicating how frequently they perform each activity, "Not at all", "1 - 4 times", or "5 or more times".
Scores range from 12 to 36 with higher scores indicating more personal advocacy behavior.
|
Change in PAAS score from Baseline to 23 weeks (12 weeks post-tx)
|
|
General Self Efficacy Scale (GSES)
Time Frame: Change in GSES score from Baseline to 11 weeks (immediately post-tx)
|
General Self Efficacy Scale (GSES) is a 10-item Likert rating scale assessing beliefs about one's ability to cope with various demands in life, a core component of self-advocacy.The GSES produces a single score ranging from 10 to 40, with higher scores indicating greater general self-efficacy.
|
Change in GSES score from Baseline to 11 weeks (immediately post-tx)
|
|
General Self Efficacy Scale (GSES)
Time Frame: Change in GSES score from Baseline to 17 weeks (6 weeks post-tx)
|
General Self Efficacy Scale (GSES) is a 10-item Likert rating scale assessing beliefs about one's ability to cope with various demands in life, a core component of self-advocacy.The GSES produces a single score ranging from 10 to 40, with higher scores indicating greater general self-efficacy.
|
Change in GSES score from Baseline to 17 weeks (6 weeks post-tx)
|
|
General Self Efficacy Scale (GSES)
Time Frame: Change in GSES score from Baseline to 23 weeks (12 weeks post-tx)
|
General Self Efficacy Scale (GSES) is a 10-item Likert rating scale assessing beliefs about one's ability to cope with various demands in life, a core component of self-advocacy.The GSES produces a single score ranging from 10 to 40, with higher scores indicating greater general self-efficacy.
|
Change in GSES score from Baseline to 23 weeks (12 weeks post-tx)
|
|
Satisfaction With Life Scale (SWLS)
Time Frame: Change in SWLS score from Baseline to 11 weeks (immediately post-tx)
|
The Satisfaction with Life Scale (SWLS) is a subjective, five-item 1-7 Likert rating scale measuring global life satisfaction - a cognitive self-assessment of quality of life.
Scores range from 5 to 35 with higher scores indicative of greater life satisfaction
|
Change in SWLS score from Baseline to 11 weeks (immediately post-tx)
|
|
Satisfaction With Life Scale (SWLS)
Time Frame: Change in SWLS score from Baseline to 17 weeks (6 weeks post-tx)
|
The Satisfaction with Life Scale (SWLS) is a subjective, five-item 1-7 Likert rating scale measuring global life satisfaction - a cognitive self-assessment of quality of life.
Scores range from 5 to 35 with higher scores indicative of greater life satisfaction
|
Change in SWLS score from Baseline to 17 weeks (6 weeks post-tx)
|
|
Satisfaction With Life Scale (SWLS)
Time Frame: Change in SWLS score from Baseline to 23 weeks (12 weeks post-tx)
|
The Satisfaction with Life Scale (SWLS) is a subjective, five-item 1-7 Likert rating scale measuring global life satisfaction - a cognitive self-assessment of quality of life.
Scores range from 5 to 35 with higher scores indicative of greater life satisfaction
|
Change in SWLS score from Baseline to 23 weeks (12 weeks post-tx)
|
|
Flourishing Scale (FS)
Time Frame: Change in total Flourishing Scale score from Baseline to 11 weeks (immediately post-tx)
|
The Flourishing Scale (FS) is a brief eight-item, self-rated, 1-7 point Likert scale measure of self-perceived success in areas such as social relationships, self-esteem, and purpose in life.
Scores range from 5 to 35 with higher scores indicating better self-perceived success.
|
Change in total Flourishing Scale score from Baseline to 11 weeks (immediately post-tx)
|
|
Flourishing Scale (FS)
Time Frame: Change in total Flourishing Scale from Baseline to 17 weeks (6 weeks post-tx)
|
The Flourishing Scale (FS) is a brief eight-item, self-rated, 1-7 point Likert scale measure of self-perceived success in areas such as social relationships, self-esteem, and purpose in life.
Scores range from 5 to 35 with higher scores indicating better self-perceived success.
|
Change in total Flourishing Scale from Baseline to 17 weeks (6 weeks post-tx)
|
|
Flourishing Scale (FS)
Time Frame: Change in total Flourishing Scale score from Baseline to 23 weeks (12 weeks post-tx)
|
The Flourishing Scale (FS) is a brief eight-item, self-rated, 1-7 point Likert scale measure of self-perceived success in areas such as social relationships, self-esteem, and purpose in life.
Scores range from 5 to 35 with higher scores indicating better self-perceived success.
|
Change in total Flourishing Scale score from Baseline to 23 weeks (12 weeks post-tx)
|
|
Participation Assessment with Recombined Tools-Objective (PART-O)
Time Frame: Change in PART-O score from Baseline to 11 weeks (immediately post-tx)
|
Objective measure of participation in society
|
Change in PART-O score from Baseline to 11 weeks (immediately post-tx)
|
|
Participation Assessment with Recombined Tools-Objective (PART-O)
Time Frame: Change in PART-O score from Baseline to 17 weeks (6 weeks post-tx)
|
Objective measure of participation in society
|
Change in PART-O score from Baseline to 17 weeks (6 weeks post-tx)
|
|
Participation Assessment with Recombined Tools-Objective (PART-O)
Time Frame: Change in PART-O score from Baseline to 23 weeks (12 weeks post-tx)
|
Objective measure of participation in society
|
Change in PART-O score from Baseline to 23 weeks (12 weeks post-tx)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2018
Primary Completion (Actual)
March 31, 2020
Study Completion (Actual)
March 31, 2020
Study Registration Dates
First Submitted
December 19, 2017
First Submitted That Met QC Criteria
December 27, 2017
First Posted (Actual)
December 29, 2017
Study Record Updates
Last Update Posted (Actual)
July 8, 2020
Last Update Submitted That Met QC Criteria
July 7, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NIDILRR SAIL 2017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on TBI (Traumatic Brain Injury)
-
Sheba Medical CenterRecruitingTraumatic Brain Injury (TBI) PatientsIsrael
-
ElMindA LtdAthletico Physical TherapyCompletedMinor Traumatic Brain Injury (TBI)United States
-
ElMindA LtdNoran Neurological ClinicCompletedHealthy | Minor Traumatic Brain Injury (TBI)United States
-
Healing Hope InternationalNot yet recruitingTraumatic Brain Injury | Traumatic Brain Injury With Brief Loss of Consciousness | Traumatic Brain Injury (TBI); Concussion, Initial Encounter | Traumatic Brain Injury (TBI); Concussion, Subsequent Encounter | Traumatic Brain Injury (TBI) Patients | Traumatic Brain Injury With Persistent Cognitive...United States, Mexico
-
ElMindA LtdYork UniversityCompletedMinor Traumatic Brain Injury (TBI)Canada
-
Indiana UniversityNot yet recruitingTraumatic Brain Injury | TBI | Traumatic Brain Injury (TBI) PatientsUnited States
-
NHS Greater Glasgow and ClydeNot yet recruitingTraumatic Brain Injury (TBI); Concussion, Initial Encounter
-
University of Texas Southwestern Medical CenterAlbert Einstein College of Medicine; National Institute of Neurological Disorders... and other collaboratorsRecruitingTBI (Traumatic Brain Injury) | TBI | Traumatic Brain Injury With Loss of Consciousness | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateUnited States
-
Institut National de la Santé Et de la Recherche...Institut National de Recherche en Informatique et en AutomatiqueRecruitingTBI (Traumatic Brain Injury)France
-
Mansoura UniversityRecruitingTBI Traumatic Brain InjuryEgypt
Clinical Trials on Self-Advocacy for Independent Life (SAIL)
-
University of New MexicoNational Heart, Lung, and Blood Institute (NHLBI); WestatRecruiting
-
Medifast, Inc.BioFortisCompletedObesity | OverweightUnited States
-
Stanford UniversityMedical Research Council, South Africa; African Institute for Health and Development...CompletedViolence, Non-accidental | Sexual Assault and RapeKenya
-
Sinai UniversityCompletedFatigue | Cognitive Dysfunction | Sleep Disorders | Chronic Rhinosinusitis | Quality of Life ImpairmentEgypt
-
Copenhagen University Hospital, HvidovreUniversity of Copenhagen; Sygekassernes Helsefond; The Danish Rheumatism Association and other collaboratorsCompletedOsteoarthritis, KneeDenmark
-
Case Comprehensive Cancer CenterTerminatedAny Cancer DiagnosisUnited States
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Chinese University of Hong KongRecruitingNon Communicable Diseases | Health-risk BehavioursHong Kong
-
Centre Antoine LacassagneUniversity of Lyon; University of Firenze and Siena, Napoli, ItalyCompleted